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        DCs are the most important APCs for mounting 
a primary immune response to foreign antigens 
(Ags) that invade the various barriers of the body 
such as the skin, gastrointestinal, and respiratory 
mucosae (  Banchereau and Steinman, 1998  ). 
DCs have been well studied and their function 
is to take up Ag across the lining barrier, inte-
grate signals on the pathogenicity of the Ag, and 
migrate via the aff  erent lymph to the regional 
draining LNs. In the T cell area of these draining 
LNs, DCs induce a tailor-made immune re-
sponse that is optimal to clear the pathogen in 
the best possible way while avoiding damage to 
self (  Banchereau and Steinman, 1998  ). Another 
portal of entry, but also a portal of dissemination 
of invading pathogens, is the bloodstream. 
Pathogens that reach the bloodstream, either 
through direct puncture of the skin or invasive-
ness through mucosal surfaces such as the naso-
pharynx or lung, are easily carried throughout 
the body. It is most often assumed that these Ags 
will be fi  ltered by the splenic microarchitecture, 
particularly the splenic marginal zone, and sub-
sequently presented by splenic DCs and/or 
macrophages to naive T cells for induction of a 
primary protective immune response (  De Smedt 
et al., 1996  ;   Morón et al., 2002  ). Some 
  bloodborne pathogens might also be fi  ltered and 
presented in the bone marrow (  Feuerer et al., 
2003  ). For pathogens that replicate and invade 
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  The bloodstream is an important route of dissemination of invading pathogens. Most of the 
small bloodborne pathogens, like bacteria or viruses, are fi  ltered by the spleen or liver sinu-
soids and presented to the immune system by dendritic cells (DCs) that probe these fi  lters for 
the presence of foreign antigen (Ag). However, larger pathogens, like helminths or infectious 
emboli, that exceed 20 μm are mostly trapped in the vasculature of the lung. To determine if 
Ag trapped here can be presented to cells of the immune system, we used a model of venous 
embolism of large particulate Ag (in the form of ovalbumin [OVA]-coated Sepharose beads) 
in the lung vascular bed. We found that large Ags were presented and cross-presented to 
CD4 and CD8 T cells in the mediastinal lymph nodes (LNs) but not in the spleen or liver-
draining LNs. Dividing T cells returned to the lungs, and a short-lived infi  ltrate consisting of 
T cells and DCs formed around trapped Ag. This infi  ltrate was increased when the Toll-like 
receptor 4 was stimulated and full DC maturation was induced by CD40 triggering. Under 
these conditions, OVA-specifi  c cytotoxic T lymphocyte responses, as well as humoral immu-
nity, were induced. The T cell response to embolic Ag was severely reduced in mice depleted 
of CD11c  hi   cells or Ly6C/G  +   cells but restored upon adoptive transfer of Ly6C  hi   monocytes. 
We conclude that the lung vascular fi  lter represents a largely unexplored site of immune 
induction that traps large bloodborne Ags for presentation by monocyte-derived DCs. 
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tion–Noncommercial–Share Alike–No Mirror Sites license for the fi  rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
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mercial–Share Alike 3.0 Unported license, as described at http://creativecommons
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  Figure 1.    Embolic large particulate Ag in the lung is presented in draining MLNs.   (A) BALB/c or C57BL/6 were injected with OVA-specifi  c CFSE-
labeled TCR Tg T cells 2 d before i.v. injection of particulate Ag (OVA  323-339   peptide, LPS-free OVA, or control glycine). At 1, 2, 4, 8, and 16 d after injection 
of particulate Ag, mice were sacrifi  ced and MLNs, PLNs, spleen, and lungs were analyzed for a T cells response. This experiment was performed three times 
with four mice at each time point. (B) Response of OVA-specifi  c CFSE-labeled CD4  +   DO11.10 T cells after injection of OBs or UBs at indicated days. MLNs, 
PLNs, and spleens were analyzed for the occurrence of OVA T cell division (CFSE profi  le, x axis) in OVA-specifi  c KJ1.26  +   T cells (y axis). Recirculating divided 
T cells are indicated in rectangles. FACS plots represent a single animal of a group of fi  ve at each day point. The experiment was performed three times. 
(C) Division profi  le (CFSE, x axis) of KJ1-26 CD4  +   DO11.10 T cells (y axis) in the lung at 2 and 4 d after injection of OB or UB. Recirculating divided 
T cells are indicated in rectangles. FACS plots represent a single animal of a group of fi  ve at each day point. The experiment was performed three times. 
(D) Confocal imaging of frozen section of lungs stained with the OVA-specifi  c TCR-specifi  c marker KJ1-26 (red). At day 4 after injection of OBs, JEM VOL. 206, November 23, 2009 
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OVA-specifi  c T cells could be found in close proximity to blood vessels (BV) and around the OB. Bars, 40 μm. (E) Whole particulate Ag is cross-presented in 
draining MLNs of the lung. At day    2,  OVA-specifi  c Tg CD8  +   CFSE-labeled OT-I were injected i.v., and at day 0, OBs (LPS free) or UBs were injected i.v. At 
day 4, MLNs were gated on CD8 T cells and analyzed for division CFSE profi  le (x axis) of V   5.1/5.2–PE-positive  OVA-specifi  c T cells (y axis). This experiment 
was performed three times with four mice per group. (F) Whole particulate Ag is presented in draining MLNs of the lung. Division CFSE profi  les (x axis) of 
CD4  +   V   5.1/5.2–PE-positive (y axis) OT-II OVA-specifi  c T cells in MLNs, 4 d after OB injection. Cells were gated for CD4 positivity. This experiment was 
performed three times with four mice per group. (G) Size of infl  ammation surrounding UBs or OBs in the lung as measured by image analysis measuring 
at days 4, 8, and 16 after injection of UBs (white bars) and OBs (black bars). Groups consisted of fi  ve mice at each day point. The experiment was per-
formed three times. Mean ± SEM of the group is depicted. *, P < 0.05.     
 
the bloodstream via the gastrointestinal tract, the portal circu-
lation can lead to fi  ltering in the liver blood sinusoids and Ag 
presentation by DCs in liver draining LNs (  Kudo et al., 1997  ). 
  Another, often neglected mechanism might exist in the 
lungs to fi  lter bloodborne pathogens. The pulmonary vascular 
system with its small diameter arterioles (20–500-μm diameter) 
and capillaries (<10-μm diameter) forms an extensive meshwork 
that receives the complete cardiac output of blood (for compari-
son, the spleen receives only 5% of cardiac output or 200–300 
ml/min). Large particles that circulate in the bloodstream (called 
emboli in the medical literature) and exceed the diameter of the 
small pulmonary vessels are very effi   ciently trapped by this sys-
tem. It is currently unknown whether Ags or pathogens that 
clog the lung vascular system would be presented to the immune 
system in a way that leads to protective immunity, which is 
analogous to the splenic or liver fi  lter system. The lung vascular 
bed is situated in the lung interstitium, where a well developed 
network of interstitial DCs and macrophages is present 
(  GeurtsvanKessel and Lambrecht, 2008  ). However, APCs of the 
lung interstitium have generally been regarded as sessile cells that 
only stimulate already primed T cells, for example, during pul-
monary delayed-type hypersensitivity reactions and granuloma 
formation (  Holt et al., 1988  ;   Gong et al., 1994  ;   Iyonaga et al., 
2002  ;   Tsuchiya et al., 2002  ). DCs are also found to line the in-
tima and adventitia of larger (pulmonary) vessel walls and, there-
fore, could probe the luminal contents for the presence of Ags, 
although it is unclear to what Ags this sampling system would re-
act (  Millonig et al., 2001  ;   Perros et al., 2007  ;   Choi et al., 2009  ). 
  The purpose of this study was to determine whether the 
lung vascular system allows Ag sampling and, thus, acts as a 
site of immune induction for T cell responses after i.v. injec-
tion of particulate Ag. For this, we injected large Sepharose 
beads coupled or not to ovalbumin (OVA). Because of their 
size (± 40–150 μm), i.v.-injected beads are specifi  cally retained 
in the vascular bed of the lung. Our studies revealed a hitherto 
unexplored potential of CD11c  +   DCs and their immediate 
monocytic precursors to sample the lung vascular compart-
ment for trapped Ag, leading to Ag presentation in lung drain-
ing LNs and generation of eff  ector responses to OVA. 
  RESULTS 
  Embolic large particulate Ag is presented and cross-
presented exclusively in the mediastinal LNs (MLNs) 
draining the lung 
  We i.v. injected large Sepharose beads coupled or not to 
OVA  323-339   peptide (coded, respectively as OVA beads [OBs] 
and uncoated beads [UBs]), the immunodominant MHCII-
restricted peptide of OVA. To allow detection of the precise 
site of primary T cell activation and division, 2 d earlier, mice 
received a cohort of CFSE-labeled CD4  +   OVA TCR trans-
genic (Tg) DO11.10 T cells (  Fig. 1 A  ), recognizing the 
OVA  323-339   peptide in the context of I-A  d   (MHCII).   The 
precise localization and degree of T cell proliferation, as mea-
sured by sequential halving of CFSE intensity with each 
round of T cell division, was measured over time in diff  erent 
anatomical compartments, including the lung, draining MLN, 
peripheral nondraining LN, and spleen, up until 16 d after 
bead injection. Proliferation of naive OVA-specifi  c T cells 
fi  rst occurred exclusively in draining MLNs of the lung 2 d 
after injection of OBs but not after injection of UBs (  Fig. 1 B  ). 
Despite the i.v. injection of Ag, no divisions were observed 
in spleen or nondraining peripheral LNs (PLNs), illustrating 
that free or particle-bound Ag did not leak from trapped Ag 
or pass beyond the lung capillary fi  lter. More specifi  cally, we 
also tested whether primary divisions were found in the liver 
draining LNs yet found no evidence for this (  Fig. S1  ). When 
we focused on the lung interstitium itself, which was ob-
tained by enzymatic digestion of a lung lobe, we could not 
detect divided T cells 2 d after injection of beads (  Fig. 1 C  ). 
When the T cell response was followed over time (  Fig. 1 B  ), 
it became evident that by day 4 after injection of OBs, di-
vided CD4  +   T cells appeared in the nondraining nodes as 
well as the spleen. These T cells had divided at least three to 
four times and expressed high levels of CD44 while having 
down-regulated the early activation marker CD69, which is 
consistent with an activated phenotype, as previously re-
ported (  Lambrecht et al., 2000  ; unpublished data). Strikingly, 
these divided cells could also be traced back to the lung inter-
stitium (by fl  ow cytometry;   Fig. 1 C  ), where they were found 
surrounding the injected OBs (by confocal imaging and im-
munostaining for DO11.10 TCR;   Fig. 1 D  ). Some OVA-
specifi  c DO11.10 T cells were seen in immediate proximity 
of lung vessels in the vicinity of OBs, suggesting a specifi  c re-
cruitment mechanism at this site. When the immune response 
was evaluated even later (days 8 and 16), it was clear that di-
vided CD4  +   T cells could no longer be traced back in the 
LNs, spleen, or lung, suggesting that they were deleted or 
their numbers had declined to a level below the threshold of 
detection by fl  ow cytometry (  Fig. 1 B  ). 
  Although these fi  ndings certainly suggested that there is a 
mechanism of immune induction for Ag trapped in the lung 
vasculature, these experiments were not conclusive as to 2826 Lung vasculature as a site for immune induction   | Willart et al. 
CD11b        conventional lung DCs, infl  ammatory type CD11b  +   
DCs, and CD11b        alveolar macrophage in the lung (  de Heer 
et al., 2004  ;   van Rijt et al., 2004  ;   Vermaelen and Pauwels, 
2004  ;   Sung et al., 2006  ;   GeurtsvanKessel et al., 2008  ). Lung 
plasmacytoid DCs (pDCs) are characterized by intermediate 
expression of CD11c and expression of Gr1 (Ly6G/C), B220, 
and the specifi   c marker BST2 (recognized by the mAb 
120G8;   Asselin-Paturel et al., 2003  ;   de Heer et al., 2004  , 
  2005  ). To analyze which subset of CD11c  +   DC was recruited 
to particulate Ag, frozen sections were stained with CD11c 
and Gr1 (recognizing Ly6C/G) or B220. Remarkably, 
CD11c  +   cells surrounding beads were Gr1  +   but lacked ex-
pression of the B220 marker, which is normally expressed on 
the surface of pDCs (  Fig. S2  ). We also stained for pDCs by 
using the pDC-specifi  c antibody 120G8, and this staining 
confi  rmed that Gr1  +   CD11c  +   DCs were not pDCs (unpub-
lished data). We did not observe signifi   cant amounts of 
CD103, which is found on a subset of CD11b        lung DCs 
(unpublished data). 
  The expression of Gr1 (Ly6G/C) on lung CD11c  +   cells 
surrounding beads was unexpected, as this marker is classi-
cally not found on lung DCs in steady state (  GeurtsvanKessel 
and Lambrecht, 2008  ;   GeurtsvanKessel et al., 2008  ). Gr1 also 
recognizes the Ly6C Ag, expressed on a subset of monocyte-
derived infl  ammatory DCs (  Randolph et al., 1999  ;   Geissmann 
et al., 2003  ;   Sunderkötter et al., 2004  ;   León et al., 2007  ;   León 
and Ardavín, 2008  ). In the mouse, circulating monocytes can 
be discriminated into Ly6C  +   CX3CR1  int   CD11b  +   mono-
cytes and Ly6C        CX3CR1  hi   CD11b  +   monocytes (  Geissmann 
et al., 2003  ). Several groups have now shown that both types 
of monocytes are immediate circulating precursors for lung 
DCs but not steady-state lymphoid tissue conventional DCs 
(  Geissmann et al., 2003  ;   Landsman et al., 2007  ;   Varol et al., 
2007  ;   Jakubzick et al., 2008  ). 
  To test the presence and diff  erentiation of monocytes 
around injected beads at earlier time points, we injected CX-
3CR  GFP   mice with OBs (  Jung et al., 2000  ). In these CX-
3CR  GFP   mice, all monocytes (and some T cells and NK cells) 
can be identifi  ed by GFP positivity and precisely localized in 
tissues using confocal imaging. As shown in   Fig. 2 C  , 6 h af-
ter injection of OBs, CX3CR  GFP+   cells were seen around 
injected beads. At the same time, Ly6C  +   and CD11c  +   cells 
were seen. The majority of cells were triple positive. It is of 
note that few cells were CX3CR1  +  Ly6C       , signifying resident 
blood monocytes, although some cells expressed CX3CR1 
and Ly6C without CD11c, representing recruited infl  amma-
tory monocytes (  Auff  ray et al., 2007  ). 
  Monocyte-derived DCs are necessary and suffi  cient 
for presentation of particulate Ag trapped 
in the lung vasculature 
  These fi  ndings of Ag presentation in the MLN draining the 
lungs and accumulation of Ly6C  +  CD11c  +   cells around in-
jected beads suggested that DCs were the major APC popula-
tion presenting bead-associated intravascular Ag to T cells. To 
address the precise contribution of CD11c  +   DCs, we used 
whether Ag would also be processed, as beads were coated 
with preprocessed OVA peptide. We therefore also studied 
whether whole OVA protein coupled to Sepharose beads 
would be processed and presented to CD4 and cross-pre-
sented to CD8 T cells. We therefore turned to the C57BL/6 
background, in which both CD4 (OT-II) and CD8 (OT-I) 
TCR Tg mice are available (  Barnden et al., 1998  ). For this, 
C57BL/6 mice received MHCI-restricted OT-I or MHCII-
restricted OT-II OVA TCR Tg T cells. In both circum-
stances, we observed T cell divisions in the MLNs 4 d after 
injection of OBs (  Fig. 1, E and F  ). Again, injection of OBs 
did not lead to T cell divisions outside the draining area of 
the lung (unpublished data). 
  In the lungs, we followed the size of the infl  ammatory le-
sions surrounding OBs or UBs. By day 4 of the response, the 
infl  ammatory lesions (as measured by the mean surface area 
of the infl  ammation minus the surface area of the bead di-
vided by the bead surface area [see Materials and methods]) 
was greatly enhanced in mice receiving OBs compared with 
UBs. However by days 8–16, all infl  ammation surrounding 
the beads had disappeared, illustrating the transient nature of 
lung infl  ammatory lesions (  Fig. 1 G  ). Together, these data 
suggested the presence of an active immune surveillance 
mechanism in the lung vascular bed that was induced in the 
mediastinal nodes. 
  Monocyte-derived DCs accumulate around particulate 
Ag trapped in the lung vasculature 
  We next addressed by which mechanism trapped Ag would 
be presented in the lung vascular bed. First, we studied the 
distribution of injected beads after i.v. injection. Injected 
beads were found exclusively in the lung vascular bed (  Fig. 2 
A  ) but not in the draining MLN, nondraining LN, or spleen 
(not depicted).   As there was Ag presentation in the MLN, 
despite absence of macroscopic beads at this site, we reasoned 
that a migratory APC population might carry antigenic cargo 
to the node. As soon as 6 h after injection of UBs or OBs, we 
detected a population of CD11c  +   cells around the injected 
beads, irrespective of whether beads were coated with OVA 
peptide (  Fig. 2 A  , days 1–16) or not (not depicted). In addi-
tion, MHC class II  +   cells started to appear around these beads 
around this time period. Double staining revealed these cells 
to be CD11c  +   and MHC class II  +   double positive, strongly 
suggesting they were DCs (  Fig. 2 A  ). When followed over 
time, the number of MHCII  +  CD11c  +   cells was increased at 
day 4 after injection of OBs compared with injection of UBs, 
a time point when infl  ammatory lesions and accumulation of 
CD4  +   T cells were also maximal (  Fig. 2 B  ). Later in the re-
sponse, CD11c  +   DCs were still present around OBs but, 
gradually, their numbers decreased. To check for the pres-
ence of myeloid cells (like monocytes, neutrophils, and some 
DC subsets), we also stained for the presence of CD11b  +   
cells. We found CD11b  +   cells to be abundantly present around 
OBs (  Fig. 2 A  , bottom). 
  The CD11c integrin is expressed on diff  erent cell types in 
the mouse lung but is mainly restricted to CD11b  +   and JEM VOL. 206, November 23, 2009 
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in DTR-Tg mice given PBS treatment there was a clear re-
cruitment of triple-positive cells 24 h after injection of OBs, 
these cells were severely reduced by DT treatment. Very 
strikingly, the depletion of CD11c  hi   cells using DT also led to 
a reduction in CX3CR  +  Ly6C  +  CD11c        infl  ammatory mono-
cytes (  Fig. 3 B  ). As the depletion of these monocytes in 
CD11cDTR Tg mice has never been demonstrated before 
and as these cells lack expression of CD11c, whose promotor 
is driving DTR expression, we hypothesized that DT treat-
ment led to a reduction of infl  ammatory monocytes indirectly. 
It has been shown that CD11c  +   cells of the lungs are a pre-
dominant source of chemokines for recruitment of other in-
fl  ammatory cell types (  Beaty et al., 2007  ). In support of this 
hypothesis, we performed stainings for monocyte chemotactic 
protein 1 (MCP-1, also known as CCL2), the major chemo-
kine recruiting CCR2  hi   infl  ammatory monocytes (  Fig. 3 C  ). 
In PBS-treated DTR-Tg mice given OBs, there was a strong 
signal for MCP-1 colocalizing with DAPI  +  CD11c  +   cells and 
mice expressing the human diphtheria toxin (DT) receptor 
(DTR) under the control of the murine CD11c promotor, 
allowing the DT-induced conditional depletion of all con-
ventional CD11c  +   DCs but leaving pDCs largely unaff  ected 
(  Jung et al., 2002  ;   Sapoznikov et al., 2007  ). We administered 
DT i.p. at the time of OB injection and followed the division 
of CFSE-labeled DO11.10 T cells. As seen in   Fig. 3 A  , T cell 
proliferation at day 4 of the response in the MLNs of CD11c-
DTR Tg mice given DT was dramatically reduced to the 
level seen in mice given UBs.   However, non-Tg littermate 
control mice given DT (or CD11c-DTR Tg mice given PBS 
[unpublished data]) still mounted a normal response to bead 
injection. The reduction of T cell proliferation in DC-de-
pleted mice was accompanied by a severe reduction in the size 
of the infl  ammatory lesions surrounding the OBs at day 4 after 
injection (unpublished data). To study if DT treatment de-
pleted local CD11c  +   cells around injected beads, we perfomed 
immunostaining for CX3CR1, Ly6C, and CD11c. Whereas 
  Figure 2.    DCs and their monocytic precursors surround trapped particulate Ag.   (A) 6-μm lung sections at 1, 2, 4, 8, and 16 d after injection of OBs 
were double stained for CD11c and MHC class II expression to identify the appearance of DCs around the particulate Ag. Furthermore, myeloid cells sur-
rounding OB were stained with an anti-CD11b antibody on a consecutive slide. UBs are not shown in A but are summarized under B. This experiment was 
performed three times with four mice per group. Bars, 40 μm. (B) Absolute number of DCs surrounding OB and UB (double stained for CD11c  +   and  MH-
CII  +  ) were counted for   n   = 4 mice per day per group. Results are shown as mean of CD11C  + MHCII +   DCs of 30 separate lesions surrounding beads ± SEM. 
*, P < 0.05. This experiment was performed twice. (C) Presence of monocytic markers on CD11c  +   cells surrounding OBs. For this purpose, C57BL/6 CX3CR-
GFP (green) Tg mice received OBs and OTII T cells. Lungs were sampled 6 h after OB i.v. injection. Slides were additionally stained for Ly-6C (red) and 
CD11c (blue). Beads are marked by dashed circles and a capital B. Overlays of a frame depicted in the top middle (rectangle) are shown in the bottom. This 
experiment was performed twice.     2828 Lung vasculature as a site for immune induction   | Willart et al. 
    Figure 3.     Monocyte-derived CD11c  +   DCs are essential and suffi  cient for priming of naive CD4  +   in lung draining MLNs in response to Ag 
trapped in the lung vasculature.   (A) Effect of DT treatment in CD11c-DTR Tg mice on Ag presentation of large embolic Ag. At day 4 after injection of 
OB, hardly any division in CFSE-labeled DO11.10 OVA-specifi  c CD4  +   T cells could be found in draining lung MLNs in DT-treated DTR-Tg mice, whereas 
strong divisions were seen at that same time point in non-Tg littermates mice receiving OB and DT or DTR-Tg mice receiving OB and PBS as a control 
treatment. (B) Effect of DT treatment on presence of monocytes and DCs around beads. 24 h after DT treatment, fewer CX3CR1  + Ly6C +   monocytes  and 
CX3CR1  + Ly6C +   CD11c +   infl  ammatory DCs were found around injected OB in CD11c-DTR-Tg mice compared with PBS treatment. Beads are marked by 
dashed circles. (C) Effect of DT treatment on monocyte specifi  c chemokines. CD11c  +   cells were depleted with DT injection on day 0 in CD11c DTR-Tg mice. JEM VOL. 206, November 23, 2009 
Article
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treated mice (Fig. S4 B), nor did it aff  ect the size of infl  am-
matory lesions (not depicted). 
  As these experiments in CD11c  +  -depleted and Gr1-
treated mice clearly demonstrated that these cells were neces-
sary for immune induction in the lung capillary fi  lter, we 
next questioned if Ly6C  +   monocytes would also be suffi   cient 
for inducing an immune response to Ag trapped in the lung 
vasculature. For this purpose, Ly6C  hi   monocytes were sorted 
from the bone marrow (based on expression of CD11b and 
Ly6C and lack of expression of CD31) and adoptively trans-
ferred i.v. in CD11c DTR Tg mice given DT around the 
time of bead injection. As seen in   Fig. 3 F  , restoration of 
OVA-specifi  c CD4  +   T cell divisions could be accomplished 
by injection of bone marrow–purifi  ed Ly6C  hi   monocytes. 
  Monocytes have also been shown to be precursors of 
Langerin  +   DCs in the lungs (  Jakubzick et al., 2008  ) and Lang-
erhans cells of the skin (  Ginhoux et al., 2006  ), and DT treat-
ment of CD11c-DTR might target these langerin  +   DCs 
directly, as they express high levels of CD11c. Therefore, we 
also addressed whether lung langerin  +   DCs were involved in 
this response by treating C57BL/6 langerin-DTR mice sys-
temically with DT. In these mice, depletion of langerin  +   cells 
had no eff  ect whatsoever on divisions of OVA-specifi  c OTII 
T cells in the MLNs, which is in sharp contrast to the same 
treatment in CD11cDTR mice (  Fig. 3 G  ). Together, these 
data therefore suggest that venous embolic Ags are fi  ltered in 
the lung vascular bed and presented by monocyte-derived 
CD11c  +   DCs in the MLNs. 
  Induction of maturation of monocyte-derived DCs 
by microbial stimuli and trimeric CD40L increases effector 
potential of T cells without affecting T cell division 
  In all our experiments, we observed that inflammatory 
lesions around the OBs eventually resolved by day 8 of the 
response. This could be a result of the fact that OBs are seen 
as relatively harmless Ags, leading to a failure of functional 
maturation in monocyte-derived CD11c  +   DCs. To address 
this point, mice were injected with OBs that were also coated 
or not with LPS and/or trimeric CD40L or as a control with 
UBs. Trimeric CD40L is an eff  ective agonist of CD40 on 
DCs and is known to induce DC maturation, particularly 
when a concomitant TLR agonist such as endotoxin is ad-
ministered (  Schulz et al., 2000  ). In mice receiving OB coated 
in combination with trimeric CD40L and LPS, there was a 
a clear MCP-1 signal localized to the DAPI  neg   extracellular 
space. However in DT-treated DTR-Tg mice, both CD11c-
associated and extracellular MCP-1 staining was abolished. 
  This data suggested that the eff  ect of DT treatment on Ag 
presentation of bead-associated Ag could be the result of di-
rect eff  ects on resident DCs or to indirect eff  ects on recruited 
monocytes that subsequently diff   erentiate to infammatory 
type DCs. To further study the contribution of infl  ammatory 
DCs in presentation of large embolic Ag, we sorted Ly6C  + 
CD11b  +  CD11c  +   infl  ammatory DCs from the MLN and lungs 
24 h after injection of OB or UB (  Fig. 3 D  ). Whereas lung-
derived infl  ammatory DCs did not present the OVA to CD4 
T cells, MLN derived infl  ammatory DCs readily did. Similar 
experiments using CD8 OVA-specifi  c T cells as a read out 
demonstrated that both MLN and lung infl  ammatory DCs 
presented to CD8 T cells (  Fig. S3  ). In contrast, autofl  uores-
cent F4/80  +  CD11c  +   alveolar macrophages did not present the 
Ag to CD4 or CD8 T cells (  Fig. 3 D   and Fig. S3). Cells with 
this phenotype were not seen to migrate to the MLN. 
  To more directly address the functional role of Ly6C  +   
monocytes and their off  spring in causing T cell proliferation 
after i.v. injection of embolic Ag, we performed depletion 
experiments in which monocytes were depleted using the 
Gr1 (Ly6C/G) antibody (  Jakubzick et al., 2008  ). Single in-
jection treatment with this antibody did not aff  ect the num-
ber of lung-resident DC subsets (unpublished data). At day 4, 
mediastinal T cell division was severely reduced in Gr1-
treated mice, compared with isotype-treated mice (  Fig. 3 E  ), 
almost down to the level of mice injected with UBs (not de-
picted). The formation of infl  ammatory lesions around in-
jected OB was also signifi  cantly suppressed and delayed until 
day 8 after injection of beads in mice depleted of Gr1  +   cells 
compared with the control isotype-treated mice, which had 
the maximum infl   ammatory lesions at day 4 (  Fig. S4 A  ). 
However, by day 16, all infl  ammatory lesions had cleared, 
even in Gr1-treated mice. The Gr1 antibody has also been 
used to deplete pDCs from the lungs of mice (  de Heer et al., 
2004  ;   Smit et al., 2006  ). To address the specifi  c contribution 
of pDCs in this response, we also treated mice with the 
depleting antibody 120G8, recognizing the more pDC-
restricted Ag bone marrow stromal Ag 2 (  Asselin-Paturel 
et al., 2003  ). The treatment with 120G8 around injection of 
OBs did not aff  ect the degree of T cell proliferation in drain-
ing MLNs at day 4 of the response, compared with isotype-
24 h after DT treatment and OB injection, no MCP-1 was found around injected beads, whereas in PBS-treated Tg mice, MCP-1 was found colocalizing 
with CD11c and in the extracellular space not containing DAPI  +   nuclei. Beads are marked by dashed circles. (D) DCs and macrophages were sorted from 
MLN and lung from mice injected with UB or OB. These APCs were subsequently put in co-culture with CFSE-labeled OT-II cells for 4 d. Autofl  uorescent 
alveolar macrophages were not detected (n.d.) in the MLNs. (E) Effect of depletion of Ly6C/G cells using Gr1 antibody. CFSE-labeled OVA-specifi  c CD4  +  
DO11.10 division profi  le in draining MLNs in mice treated with anti-Gr1 or isotype i.p. at day 0 and injected with OB, measured at day 4. (F) Ly6C  hi   mono-
cytes restore T cell division in CD11c-depleted mice. CD11c/DTR-Tg mice or non-Tg littermates (nTg) received CFSE-specifi  c OVA-specifi  c CD4  +   T cells at 
day     2, with DT at day 0, with either UB (nTg) at day 0 or OB (nTg) at day 0, or OB at day 0 (DTR-Tg mice) with or without 3.5 × 10  5   bone  marrow–puri-
fi  ed (>99%) Ly6C  hi   CD11b hi   monocytes.  CD4 +   OVA-specifi  c T cell divisions in these groups are shown in draining MLNs at day 4 after UB or OB injection. 
DTR-Tg mice depleted of CD11c  +   by DT show reconstitution of divisions by monocyte i.v. injection at day 0. (G) Depletion of langerin  +   lung DCs, using DT 
injection, in langerin-DTR mice showed no effect on OVA-specifi  c T cell proliferation, compared with nTg mice given DT. These experiments were per-
formed two to fi  ve times with fi  ve mice per group per time point.     
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  Figure 4.    Effect of triggering TLR4 receptor and CD40 on Ag presentation to Ag trapped in the lung vasculature.   (A) Mice received OVA-
specifi  c CD4  +   DO11.10 T cells at day     2, and UBs, OBs, OB co-coated with LPS (LPS-OB), or OB co-coated with LPS and trimeric CD40L (LPS-CD40L-OB) at 
day 0. 4 d later, infl  ammation surrounding the beads is shown in these groups. Bars, 100 μm. (B) Size of infl  ammation surrounding the beads in the lungs 
in these groups is shown at days 4, 8, and 16. Data are shown as mean (  n   = 4 mice/group) ± SEM. *, P < 0.05. (C) Representative fl  ow cytometry analyses 
of (  n   = 4 per group) OVA-specifi  c CD4  +   T cell divisions in draining lung MLNs at day 4 are shown. (D) Cytokine production in cultures of MLN, restimulated 
for 4 d in the presence of OVA Ag. The level of IL-4 was at the detection limit of the IL-4 ELISA (15 ng/ml). *, P < 0.05. Error bars represent statistical sig-
nifi  cance between these groups. (E) IFN-     production by T cells was also analyzed in supernatant of restimulated MLN cells, from mice injected with 3 × JEM VOL. 206, November 23, 2009 
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10  3   UB, 10  3   OB combined with 2 × 10  3   UB,  10 3   LPS-aCD40 OB combined with 2 × 10  3   UB, or mixed beads. The mice receiving mixed beads were injected 
with 10  3   OB, 10  3   LPS-B, and 10  3      -CD40-B. Therefore, all mice received the same number of beads and the same amount of Ag. *, P < 0.05. Error bars 
represent statistical signifi  cance between these groups. (F) To analyze the OVA-specifi  c effector T cell function in this model, mice were injected with UB, 
OB, or LPS–    -CD40-OB and, after 6 d, injected subcutaneously with OVA peptide–pulsed DCs mixed with unpulsed DCs, respectively CMTMR and CFSE 
labeled. This graph shows the ratio of alive OVA peptide DCs versus unpulsed DCs, 4 d after injection of target DCs. *, P < 0.05. Error bars represent statis-
tical signifi  cance between these groups. (G) In serum of these mice, OVA-specifi  c IgG  1   levels were measured by ELISA. *, P < 0.05. Error bars represent 
statistical signifi  cance between these groups. These experiments were done three times with fi  ve mice per group.     
 
strong increase in the size of infl  ammatory lesions around the 
OBs (  Fig. 4 A  , infl   ammatory lesions at day 4 after bead 
injection).   LPS co-coating of OB by itself was insuffi   cient 
to obtain this eff  ect (  Fig. 4, A and B  ). This enhancing eff  ect 
was maintained until day 16 after injection of beads, al-
though infl  ammatory lesions became much smaller compared 
with those seen on day 4 (  Fig. 4 B  ). Despite the occurrence 
of larger infl   ammatory lesions around OBs with LPS and 
sCD40L, at day 16 all infl  ammatory lesions were again re-
solved. Provision of these DC-maturing stimuli did not aff  ect 
the strength of T cell divisions in the MLN at day 4 after OB 
injection (  Fig. 4 C  ). When the amount of cytokine produc-
tion was measured in cultures of MLN, restimulated for 4 d 
in the presence of OVA Ag, the addition of LPS and/or 
sCD40L clearly enhanced the production of IFN-    , whereas 
IL4 remained at the detection limit of the ELISA (  Fig. 4 D  ). 
To address whether CD40 and TLR4 triggering had to occur 
physically on the same particulate OB, mice received beads 
coated simultaneously with OVA, LPS, and anti-CD40 or 
mice received beads coated separately with OVA, LPS, or 
anti-CD40. OB and LPS-aCD40 OB-injected mice also 
received 2/3 UB to equalize the amount of beads and the 
amount of OVA Ag given between groups. As shown in 
  Fig. 4 E  , restimulated MLN cells secreted more IFN-     when 
the beads were coated with OVA, LPS, and     -CD40 simul-
taneously, compared with mice given a mixture of separately 
labeled OB, anti-CD40 beads, and LPS beads. We also ad-
dressed whether injection of OBs in conjunction with CD40 
and TLR4 triggering led to induction of CTL responses to 
OVA-pulsed target cells. For this, we injected an equal 
amount of OVA-pulsed or unpulsed BM-DC targets, stained, 
respectively, with CMTMR and CFSE (  Ritchie et al., 2000  ). 
As shown in   Fig. 4 F  , simultaneous triggering of CD40 and 
TLR4 on beads led to induction of OVA-specifi  c lytic eff  ec-
tors that killed 50% of injected OVA-pulsed DCs, whereas 
injection of UBs or OVA-LPS–coated beads did not have 
this eff  ect. Finally we also addressed the induction of humoral 
OVA-specifi  c immunity by injection of these beads. We ob-
served induction of OVA-specifi  c IgG  1   after injection of OBs 
already when only TLR4 was triggered, whereas injection of 
UBs did not induce OVA-specifi  c antibodies. 
  DISCUSSION 
  In this paper, using a system of traceable Ag-reactive T cells 
specifi  c to OVA, we report that the meshwork of small lung 
vessels allows the eff  ective fi  ltering of large embolic Ags fol-
lowed by uptake of the Ag by monocyte-derived CD11c  +   
DCs and Ag presentation to CD4  +   and CD8  +   T cells in the 
MLNs. Primed T cells subsequently return to the lung and 
form short-lived infl   ammatory lesions that are ultimately 
cleared. This response clearly depends on Ly6C  +   monocytes 
and CD11c  hi   DCs, as it is eliminated in mice with a condi-
tional deletion of CD11c  +   cells and depleted of Gr1 (Ly6C/G)  +   
cells, and restored by adoptive transfer of Ly6C  hi   monocytes 
(  Jung et al., 2002  ). These data, therefore, identify a third fi  l-
tering network for bloodborne Ags, in addition to the spleen 
and liver, that is specialized for immune induction against 
large embolic material. 
  Strikingly, early after injection of embolic material, there 
was an accumulation CD11c  +  MHCII  +   DCs surrounding the 
injected beads of which the origin can be debated. One possi-
bility is that the resident interstitial DCs of the lung that can 
be found in alveolar septa would migrate to the occluded ves-
sels and sample the vessel content. Numerous studies in mouse 
and rat have indeed demonstrated that alveolar septa contain 
DCs in close proximity to small diameter arterioles and alveo-
lar capillaries (  Sertl et al., 1986  ;   Holt et al., 1988  ,   1992  ). How-
ever, these interstitial DCs have classically been described as 
sessile cells that fail to migrate to draining LNs and would 
merely restimulate already primed T cells during pulmonary 
delayed-type hypersensitivity–like reactions (  Kradin et al., 
1993  ;   von Garnier et al., 2005  ). Another possible explanation 
would be that DCs accumulated on the injected beads from 
within the vessel lumen. Pulmonary vessels already contain a 
large marginating pool of DC precursors, possibly hardwired 
for Ag recognition at this site. This has been suggested by 
  Suda et al. (1998)  , who demonstrated that the blood cannu-
lated from the lungs of rats contained much more DC precur-
sors than vena cava–cannulated blood, and these cells obtained 
DC potential after culture in appropriate cytokines. Whether 
this sequence of DC diff  erentiation from vascular precursors 
would occur in our system remains to be shown. 
  Although all of these scenarios are not mutually exclusive, 
we favor a third potential source for bead-associated CD11c  +   
DCs. Ag presentation in our system of i.v. embolization oc-
curred as the result of Ag recognition by Gr1  +   (Ly6C/G) 
CD11c  +   cells that accumulated as early as 6 h after bead injec-
tion. These cells most likely represented monocyte-derived 
DCs and not pDCs, as they lacked expression of B220 and 
120G8. The evidence for this comes from the coexpression of 
the fractalkine (CX3CR) receptor, Ly6C, and CD11c on these 
cells and the fact that T cell proliferation and development of 
infl  ammatory lesions in the lung were signifi  cantly reduced 
when mice were depleted of Gr1 (Ly6G/C)  +   cells but not by 2832 Lung vasculature as a site for immune induction   | Willart et al. 
monocytes not expressing CD11c. Strikingly, a lot of the 
MCP-1 was found not associated with the DAPI nuclear sig-
nal. Previously, MCP-1 was found indeed to be able to me-
diate its chemotactic eff   ects at a distance from its site of 
production, displayed on extracellular matrix proteoglycans 
(  Palframan et al., 2001  ). However, the extracellular MCP-1 
signal was completely eliminated in DC-depleted mice, sug-
gesting that a CD11c  hi   cell was the predominant source for 
extracellular MCP-1. The exact subtype of lung DCs ex-
pressing MCP-1 in our model remains to be established. 
Resident CD11c  +  CD11b  +  CD103  neg   DCs are found in the 
lung interstitium and have been shown to be a prominent 
source of chemokines (  Beaty et al., 2007  ). Recently also,   Choi 
et al. (2009)   identifi   ed a population of vascular CD11c  + 
CD11b  +   cells that probes the large systemic vessels. 
  One surprising observation of this and other models of 
embolization, such as injection of   Schistosoma mansoni   soluble 
Ag-coated or   Mycobacterium   PPD Ag-coated Sepharose beads, 
was that infl  ammatory lesions around injected embolic mate-
rial were very short lived (  Chensue et al., 1994  ;   Iyonaga et al., 
2002  ). It is also known that parasites or parasite eggs that 
gain access to the venous system as part of their replicative 
cycle end up in the lung arterioles and capillaries, leading to 
formation of lung granulomas or transient pulmonary infl  am-
matory infi  ltrates (called Löffl   er’s syndrome). One explana-
tion of these fi   ndings would be that, like in our model, 
monocyte-derived CD11c  +   DCs would not get the proper 
activation status to induce full blown eff  ector cells, thus lead-
ing to a program of deletional proliferation of T cells. In sup-
port of this, IFN-     cytokine production of dividing T cells of 
mice receiving OBs was not above the level seen in mice re-
ceiving UBs. Arguing against this possibility is the fact that 
injection of CD40 and LPS, two known activators of the DC 
system and its potential to produce IL12p70 (  Schulz et al., 
2000  ), enhanced the size of the infl  ammatory lesions, pro-
duction of IFN-     by dividing T cells, production of IFN-     
by tissue-infi  ltrating T cells, and lytic activity of CD8 CTLs, 
but eventually these were still cleared from the lung. Also, 
models in which PPD-coated beads or   S. mansoni   eggs are 
injected would lead to full DC activation, but still these gran-
ulomata are cleared eventually (  Iyonaga et al., 2002  ). Such a 
system to clear the lung interstitial tissue of overt infl  amma-
tory lesions makes evolutionary sense as this is the site of vital 
gas exchange (  Lambrecht, 2006  ). Several mechanisms in the 
lung, such as the suppressive function of the nearby alveolar 
macrophage with its secretion of antiinfl  ammatory factors, 
such as TGF-    , IL1-RA, IL-10, and prostaglandins, might 
keep infl  ammation in check by down-regulating the Ag-pre-
senting capacity of DCs (  Holt et al., 1988  ;   Iyonaga et al., 
2002  ). Alternatively, early fi  brosis occurring around injected 
beads could eff  ectively shield off   the Ag so that it is further 
ignored by the immune system, eventually leading to apop-
tosis of T cells (  Hogaboam et al., 1999  ). 
  In conclusion, we have provided evidence for a highly 
active Ag sampling mechanism for embolic material trapped 
in the small vessels of the lung that can potentially lead to the 
depletion of 120G8  +   cells. In previous studies, Ly6C  +   mono-
cytes have been shown to be precursors for infl  ammatory-type 
DCs, thus acquiring APC function and expression of the 
CD11c marker, and most likely represent the immediate pre-
cursor to nature’s adjuvant, the immunogenic DC (  Serbina 
et al., 2003  ;   Le Borgne et al., 2006  ;   Naik et al., 2006  ;   León et al., 
2007  ;   Shortman and Naik, 2007  ;   Kool et al., 2008  ). In the 
mouse, circulating monocytes can be discriminated into Ly6C  +   
CX3CR  int   CD11b  +   infl   ammatory monocytes and Ly6C        
CX3CR  hi   CD11b  +   monocytes (  Geissmann et al., 2003  ). Sev-
eral groups have now shown that both types of monocytes are 
also immediate circulating precursors for lung DCs but not 
steady-state lymphoid tissue DCs (  Geissmann et al., 2003  ; 
  Landsman et al., 2007  ;   Varol et al., 2007  ;   Jakubzick et al., 
2008  ). Strikingly, Ly6C  hi   monocytes express the CCR2 recep-
tor for MCP-1. Although we have not measured the level of 
this chemokine, others using an injection model of Schisto-
somal egg antigen or   Mycobacterium   purifi  ed protein derivate 
(PPD)–coated Sepharose beads could measure an early pro-
duction of this chemokine by lung structural cells (  Hogaboam 
et al., 1999  ). Supporting a crucial role for infl  ammatory mono-
cytes in early granuloma formation, CCR2-defi  cient mice had 
a defect in early (day 1–2) granuloma formation. It will be in-
teresting to study whether these CCR2-defi  cient mice also 
have a reduced DC accumulation around beads and delayed 
Ag presentation in our model. This could be a possibility, as 
CCR2 was shown to be crucial for DC recruitment to the 
other lung compartment, the airway mucosa, under infl  amma-
tory conditions (  Robays et al., 2007  ). Alternatively, a popula-
tion of CX3CR  med   Ly6C        monocytes has been shown to patrol 
the inside of the vessel wall (  Auff  ray et al., 2007  ;   Geissmann 
et al., 2008  ) We do not believe, however, that this subset was 
involved in presenting trapped embolic Ag in the lung, as the 
majority of CX3CR  gfp+   cells were Ly6C  +   and depletion of 
Gr1  +   cells abolished most Ag presentation, whereas adoptive 
transfer of Ly6C  hi   monocytes restored it. 
  Systemic DT treatment of CD11c-DTR at the time of 
bead injection led to a reduction of CX3CR1  +  Ly6C  +  CD11c  +   
DCs and infl  ammatory  CX3CR1  +  Ly6C  +  CD11c        mono-
cytes around injected OB. These fi  ndings were very striking, 
as injected DT only kills cells expressing high level CD11c 
and circulating monocytes with this phenotype have not 
been described to be depleted in these mice (  Geissmann et al., 
2003  ;   Landsman et al., 2007  ;   Sapoznikov and Jung, 2008  ). 
The fact that DT has a very short half-life also did not support 
a model in which CD11c (and consequent DTR expression) 
was up-regulated on monocytes after recruitment to the 
beads, rendering monocytes sensitive to DT. We favor a 
model in which resident CD11c  +   DCs act as gatekeepers that 
chemoattract the infl  ammatory DCs, which, in their turn, are 
the true vehicles of immunity. In support of this, we found 
that CD11c  +   DCs were a predominant source of MCP-1, the 
major chemokine attracting CCR2  +   infl  ammatory  mono-
cytes. In CD11c-DTR Tg mice, treatment with DT largely 
eliminated the presence of MCP-1 around the injected beads, 
explaining how DT treatment can also lead to a reduction in JEM VOL. 206, November 23, 2009 
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  Detection of the primary T cell response to OB injection i.v.     On 
days 1, 2, 4, 8, and 16, MLNs, PLNs (axillary), spleens, and lungs were re-
moved, and individual cell suspensions were prepared as previously described 
(  Lambrecht et al., 2000  ). Cell suspensions were stained either with antibod-
ies to CD4, CD8, KJ1-26 (specifi  c anti-TCR antibody for the TCR recog-
nizing OVA peptide in I-A  d  ), or V    5.1/5.2. Propidium iodide (Sigma-
Aldrich) was added for exclusion of dead cells before analysis of CFSE 
profi  les on a FACSCalibur fl  ow cytometer using CellQuest (BD) and FlowJo 
software (Tree Star, Inc.). 
  For measurement of cytokine responses, cell suspensions obtained from 
MLNs were cultured at 200,000 cells per well in the presence of 10 μg/ml 
OVA protein. IL-4 and IFN-     were measured at day 4 by ELISA (BD). 
  Depletion of DCs and monocytes.     In experiments to address the func-
tional role of DCs in infl  ammation formation around beads, CD11c  +   cells 
were depleted by injecting 100 ng DT i.p. in CD11c-DTR Tg mice (  van 
Rijt et al., 2005  ). The same dose is used in Langerin DTR mice to deplete 
the Langerin  +   cells. In experiments to address the functional role of pDCs, 
pDCs were depleted by 120G8 antibody injection (200 μg at the day of bead 
injection; provided by C. Asselin-Paturel, Shering-Plough, Dardilly, France; 
  Asselin-Paturel et al., 2003  ). For monocyte depletion, anti-Gr1 i.p. injection 
was used, which was given at 200 μg on the same day of bead injection. 
  In experiments to address if monocytes could restore immune responses 
in the DT-treated CD11c-DTR Tg mice, 3.5 × 10  5   CD11b  +  Ly-6C  +  CD31        
monocytes sorted from bone marrow of RAG2       c        /      BALB/c mice 
(  Geissmann et al., 2003  ) were injected i.v. on day 0 after OB or UB injec-
tion. To investigate whether DCs migrated to the draining LNs and present 
OVA, DCs were sorted from the MLN and lung from mice that were injected 
4 d earlier with OB and control mice that were injected with UB. Macro-
phages were sorted from the lungs of these mice as a control of APCs. 
  DCs and macrophages were subsequently brought in and co-cultured 
for 4 d with CFSE-labeled OT-I and OT-II cells to analyze their presenting 
capacity. Monocytes, DCs, and macrophages were sorted on a cell sorter 
(FACS-ARIAII; BD). 
  CTL response.     C57BL/6 mice were injected with 10 × 10  6   unlabeled OT-
I T cells and, 2 d later, with UB, LPS-OB, or LPS-aCD40-OB. DCs were 
cultured for 6 d from bone marrow of C57BL/6 mice with GM-CSF. At 
day 6, half of the DCs were pulsed with OVA peptide (10 μM SIINFEKL) 
for 2 h. These cells were harvested and labeled with 10 μM CMTMR (10 × 
10  6   cells/ml) according to the manufacturer’s protocol (Invitrogen). The 
unpulsed DCs were harvested and fl  uorescently labeled with 10 μM CFSE. 
Both types of DCs were mixed in a 1:1 ratio and injected 6 d after the sub-
cutaneous bead injection. After another 4 d, the inguinal LNs were dissected 
and the migrated CMTMR  +   DCs and CFSE  +   DCs were analyzed by FACS. 
Serum was collected from these mice and OVA-specifi  c IgG  1   levels were 
detected with ELISA (BD). 
  Confocal microscopy.     Confocal analysis was performed on 6-μm cryostat 
sections of lungs stained with anti-CX3CR1/goat anti–rabbit FITC (Acris 
Antibodies), anti-Gr1 FITC, anti-B220 PE, Ly-6C biotin-streptavidin Alexa 
Fluor 555, CD11c Alexa Fluor 647, rabbit anti-MCP-1 (Abcam)/donkey 
anti–rabbit Cy3 (Jackson ImmunoResearch Laboratories, Inc.), and 120G8 
coated with Quantum dots (Micro Probe, Inc.). Sections were collected on 
a confocal laser microscope (LSM-710; Carl Zeiss, Inc.) and analyzed using 
Imaris 5.0 software (Bitplane). 
  Immunohistochemistry and analysis of infl  ammation surrounding 
beads.     For immunohistochemistry analysis of the infl  ammation, 6-μm cryo-
stat sections of lungs were stained with CD11c, CD11b, and MHCII. For 
infl  ammation size, hematoxylin-counterstained lungs were analyzed with an 
image analysis system (Quantimed; Leica), whereby 30 beads per mice were 
measured, dividing the surface size of the bead (in micrometers squared) by 
the surface size of infl  ammation and bead together (in micrometers squared). 
30 beads were chosen to attain a mean bead diameter, as slides were 6 μm. 
generation of eff  ector T cell responses when properly trig-
gered. It is likely that this system developed during evolution 
to allow the immune system to eff  ectively recognize large 
particulate Ags acquiring access to the venous blood by inva-
sion, such as parasite eggs or worms, or after direct (trau-
matic) access to the bloodstream. When such Ags would be 
retained in the lungs without a possibility for Ag recognition, 
this could lead to a very eff  ective way of pathogen immune 
subversion, as the spleen or liver, two other major sites of 
immune induction against blood particulate Ags, cannot ac-
cess these large Ags and the pathogen could mutate during 
residence in the lung. It will be interesting to study whether 
certain pathogens take advantage of this system by blocking 
DC migration to the mediastinal nodes. It could also be that 
allogenic cells disrupted as a group of cells from freshly trans-
planted vascularized organs are presented via this route, as 
these vascularized grafts lack a direct connection with aff  erent 
lymph and the lung vascular bed is the fi  rst small vessel fi  lter 
encountered. Clearly, this pathway of immune induction in 
the lung vasculature deserves further study. 
  MATERIALS AND METHODS 
  Mice.     6–8-wk-old female BALB/c (H-2  d  ) and C57BL/6 mice were pur-
chased from Harlan. OVA-TCR Tg mice (DO11.10) on a BALB/c back-
ground, OT-II and OT-I OVA-TCR Tg mice on a C57BL/6 background, 
CD11c-DTR Tg mice on a BALB/c background, and Langerin DTR Tg 
mice on a C57bl/6 background (  Bennett et al., 2005  ) were bred at Erasmus 
University (Rotterdam, Netherlands) and University of Ghent (Ghent, Bel-
gium). CX3CR-GFP on a C57BL/6 background was a gift from S. Jung 
(Weizmann Institute of Science, Rehovot, Israel;   Jung et al., 2000  ). Mice 
were housed under specifi  c pathogen-free conditions at the animal care facil-
ity at Erasmus University. All of the experimental procedures used in this 
study were approved by the Erasmus University Committee of Animal Ex-
periments and the Animal Ethics Committee of the University of Ghent. 
  Reagents and antibodies.     OVA  323-339   peptide was obtained from Ansynth 
Service B.V. OVA protein was obtained from Worthington Biochemical 
Corporation. CNBr-activated Sepharose 4B beads were obtained from 
Sigma-Aldrich. CFSE and CellTracker Orange (CMTMR) were obtained 
from Invitrogen. FITC-labeled anti-Gr1 (RB6-8C5) and PE-labeled KJ1-26 
(clonotypic OVA-TCR) were obtained from Invitrogen, PE-Labeled anti-
B220 (RA3-6B2), CD8-     (Ly-2), V    5.1/5.2, and APC-labeled anti-CD4 
(RM4-5) were purchased from BD. Unconjugated anti-CX3CR1 and goat 
anti–rabbit FITC were obtained from Acris Antibodies. 
  Intravascular injection of emboli.     BALB/c or C57BL/6 mice received 
i.v. in the lateral tail vein 10  4   OVA-coated (OB) or noncoated (glycine; 
UB) CNBr-activated Sepharose 4B beads on day 0. Beads between 40 and 
150 μm in diameter were prepared and coated with OVA, as described by 
others (  Chensue et al., 1994  ), and were concentrated on a 40-μm cell strainer 
to remove smaller beads. Because of low OVA-TCR–specifi  c naive T cell 
frequency in these wild type BALB/c mice, 10 × 10  6   live CFSE-labeled 
OVA-TCR Tg naive DO11.10 T cells were given i.v. 2 d before injection 
of the beads (day –2). OVA-specifi  c TCR Tg T cells were collected from 
the lymphoid organs of naive 4–6-wk-old DO11.10, OT-I, or OT-II 
mice and stained with CFSE (Invitrogen), as previously described (  de 
Heer et al., 2004  ). 
  In some experiments, to address the role of DC maturation, mice also 
received OB co-coated with LPS (LPS-OB; LPS obtained from Sigma-
Aldrich) or OB co-coated with LPS and trimeric CD40L (2 μg/ml sCD40L, 
100 ng/ml LPS; LPS-CD40L-OB). Agonistic anti-CD40 was used at 200 
ng/ml. Trimeric CD40L was a gift from Amgen. 2834 Lung vasculature as a site for immune induction   | Willart et al. 
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